Viewpoint Molecular Targeting, Inc.

Amendment
CIK: 0001768245·Biotechnology·DELAWARE·Filed: Jun 18, 2020
Total Offering

$2,000,000

Amount Sold

$750,000

Investors

10

First Sale

Feb 6, 2019

Offering Details

Type
Debt
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Frances Johnson
Related Person
Michael Schultz
Related Person
Heyward Coleman
Related Person
Curtis Nelson
Related Person

Company

Viewpoint Molecular Targeting, Inc.

2500 CROSSPARK ROAD E-116

CORALVILLE, IA, 52241

8653561861

SEC Filing

0001768245-20-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Viewpoint Molecular Targeting, Inc. Form D Filing — $2,000,000 | FilingFlow